Clinical Trial Diversity Scorecard

---

CARER Group co-founder William Fitzsimmons, a life sciences entrepreneur and academic, spearheaded the creation of the CARER Clinical Trial Diversity Scorecard. 

This instrument was designed to evaluate diversity in the registrational clinical trials for novel drugs and biological products approved by US Food & Drug Administration.

The diversity criteria examined on this scorecard are Age, Sex, Race, and Ethnicity.

Our aim is to ensure that all groups will be appropriately represented in future clinical trials.